Characterization of Cre recombinase activity for in vivo targeting of adipocyte precursor cells.

Stem Cell Reports

Department of Pediatrics/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA; Cardiovascular Institute, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA; Program in Regenerative Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA. Electronic address:

Published: December 2014

The increased incidence of obesity and metabolic disease underscores the importance of elucidating the biology of adipose tissue development. The recent discovery of cell surface markers for prospective identification of adipose precursor cells (APCs) in vivo will greatly facilitate these studies, yet tools for specifically targeting these cells in vivo have not been identified. Here, we survey three transgenic mouse lines, Fabp4-Cre, PdgfRα-Cre, and Prx1-Cre, precisely assessing Cre-mediated recombination in adipose stromal populations and mature tissues. Our data provide key insights into the utility of these tools to modulate gene expression in adipose tissues. In particular, Fabp4-Cre is not effective to target APCs, nor is its activity restricted to these cells. PdgfRα-Cre directs recombination in the vast majority of APCs, but also targets other populations. In contrast, adipose expression of Prx1-Cre is chiefly limited to subcutaneous inguinal APCs, which will be valuable for dissection of APC functions among adipose depots.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264060PMC
http://dx.doi.org/10.1016/j.stemcr.2014.10.009DOI Listing

Publication Analysis

Top Keywords

precursor cells
8
adipose
6
characterization cre
4
cre recombinase
4
recombinase activity
4
activity vivo
4
vivo targeting
4
targeting adipocyte
4
adipocyte precursor
4
cells
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!